NCT06382857

Effectiveness of a Microbiome-directed Food to Promote Programmatic and Sustained Nutritional Recovery Among Children With Uncomplicated Acute Malnutrition

Name: Clinical Trial NCT06382857
Creator: Epicentre
Keywords: Malnutrition, Child, MDF, dietary supplement, clinical trial, Niger

Epicentre·ClinicalTrials.gov·dietary supplementRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Malnutrition, Child
Drug/Device/Intervention: MDF
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Epicentre
Location: Maradi, Niger

Timeline & enrollment

Phase: N/A
Start date: May 02, 2024
End date: Feb 01, 2026
Enrollment: 7356 participants

Primary outcome

Programmatic recovery by 12 weeks from admission,Sustained recovery at 24 weeks from admission

Summary

This study is an individually randomized controlled trial comparing microbiome-directed foods to standard nutritional therapy among children aged 6 to 24 months with uncomplicated acute malnutrition in terms of programmatic recovery by 12 weeks from admission and sustained recovery at 24 weeks from admission.

ICD-10 classifications

MalnutritionMalnutrition in pregnancySequelae of malnutrition and other nutritional deficienciesMalnutrition-related diabetes mellitusMalnutrition-related diabetes mellitus with unspecified complications

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06382857
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06382857 through Pure Global AI's free database. This phase not specified trial is sponsored by Epicentre and is currently Recruiting. The study focuses on Malnutrition, Child. Target enrollment is 7356 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.